Loader

Pathways

PathWhiz ID Pathway Meta Data

PW146029

Pw146029 View Pathway
drug action

Technetium Tc-99m pyrophosphate Drug Metabolism Action Pathway

Homo sapiens

PW132252

Pw132252 View Pathway
metabolic

Technetium Tc-99m sestamibi Drug Metabolism

Homo sapiens
Technetium Tc-99m sestamibi is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Technetium Tc-99m sestamibi passes through the liver and is then excreted from the body mainly through the kidney.

PW146026

Pw146026 View Pathway
drug action

Technetium Tc-99m sestamibi Drug Metabolism Action Pathway

Homo sapiens

PW132255

Pw132255 View Pathway
metabolic

Technetium Tc-99m succimer Drug Metabolism

Homo sapiens
Technetium Tc-99m succimer is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Technetium Tc-99m succimer passes through the liver and is then excreted from the body mainly through the kidney.

PW146153

Pw146153 View Pathway
drug action

Technetium Tc-99m succimer Drug Metabolism Action Pathway

Homo sapiens

PW146135

Pw146135 View Pathway
drug action

Technetium Tc-99m sulfur colloid Drug Metabolism Action Pathway

Homo sapiens

PW132262

Pw132262 View Pathway
metabolic

Technetium Tc-99m tetrofosmin Drug Metabolism

Homo sapiens
Technetium Tc-99m tetrofosmin is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Technetium Tc-99m tetrofosmin passes through the liver and is then excreted from the body mainly through the kidney.

PW146025

Pw146025 View Pathway
drug action

Technetium Tc-99m tetrofosmin Drug Metabolism Action Pathway

Homo sapiens

PW146057

Pw146057 View Pathway
drug action

Technetium Tc-99m tilmanocept Drug Metabolism Action Pathway

Homo sapiens

PW127608

Pw127608 View Pathway
drug action

Tecovirimat Action Pathway

Homo sapiens
Tecovirimat (Tpoxx) is an antiviral used in the treatment of smallpox, monkeypox and cowpox. In fact, this drug is effective against all orthopoxviruses, including vaccinia, cowpox, ectromelia, rabbitpox, monkeypox and variola virus (smallpox). Tecovirimat was approved by the FDA in July 2018. Tecovirimal is an inhibitor of the P37 protein (VP37 envelope-wrapping protein)) of the orthopoxvirus. This protein is essential to form the wrapping complex of mature virions with late endosomal membranes by interacting with proteins such as Rab9 GTPase and TIP47.. The P37 protein is encoded by a highly conserved gene in all members of the orthopoxvirus genus. When Tecovirimat binds P37, this protein can not interact with the Rab9 GTPase and TIP47, which are components of late endosome-derived transport vesicles. In consequence, there is no formation of the wrapping complex for enveloped virions. This drug is available as an oral tablet and an intravenous formulation.